At-Home COVID-19 Antibody Test Usability Assessment & Behavior Change Study

Status unconfirmed · Not applicable

Conditions studied: COVID19, COVID-19, Coronavirus

In brief

Radish Health and ProofPilot in coordination with Sanesco are running this study to help establish whether the Premier Biotech COVID-19 IgG/IgM Rapid Test Cassette (Whole Blood/Serum/Plasma Authorized for distribution under emergency use authorization - though not yet FDA reviewed) can be conducted effectively at home to detect COVID-19 antibodies among individuals who have tested positive, or suspect they have previous contracted from COVID-19 and recovered. The study also aims to examine how the results of those tests change social-distancing behaviors and general anxiety over 8 weeks post-test.

Key facts

Study ID

NCT04393961

Run by

ProofPilot

People needed

600

Starts

2020-04-05

Expected to finish

2020-08-29

Last updated by the study team

2020-05-19

Who can join

Age: 18 and older, up to 100. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Reside and Currently in New York City
• Does not have a blood clotting disease
• Is not abnormally queasy about taking a blood sample
• Not on any blood thinning medications
• Able to consent
• Willingness to take a blood sample
• Confirmed of highly likely past infection with COVID-19 over 14 days ago and fully recovered

Where it is running

• ProofPilot Online App (https://p.proofpilot.com) — New York, New York, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.